| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.01 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.26 | 0.01 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |